CLINICAL_TRIALS
trial_result
· 2021-05-10
Clinical Trial Update: caBozantinib in cOllectiNg ductS Renal Cell cArcInoma [Phase 2]
Summary
Phase 2 trial of caBozantinib in collecting duct carcinoma of the kidney completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Conditions: Collecting Duct Carcinoma (Kidney) | Phase 2 | Status: COMPLETED